Trial Profile
A Phase 3 trial of RAYALDEE in dialysis patients.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 18 Nov 2016
Price :
$35
*
At a glance
- Drugs Calcifediol (Primary)
- Indications Hyperparathyroidism; Renal failure
- Focus Therapeutic Use
- 18 Nov 2016 New trial record